Biomedical Engineering Reference
In-Depth Information
Risbridger, G.P., Almahbobi, G.A., and Taylor, R.A. 2005. Early prostate development and
its association with late-life prostate disease. Cell Tissue Res. 322:173-181.
Rizzo, S., Attard, G., and Hudson, D.L. 2005. Prostate epithelial stem cells. Cell Prolif.
38:363-374.
Robinson, E.J., Neal, D.E., and Collins, A.T. 1998. Basal cells are progenitors of luminal cells
in primary cultures of differentiating human prostatic epithelium. Prostate 37:149-160.
Rubin, L.L. and De Sauvage, F.J. 2006. Targeting the Hedgehog pathway in cancer. Nat.
Rev. Drug Discov. 5:1026-1033.
Salm, S.N., Burger, P.E., Coetzee, S., Goto, K., Moscatelli, D., and Wilson, E.L. 2005. TGF-{beta}
maintains dormancy of prostatic stem cells in the proximal region of ducts. J. Cell Biol. 170:81-90.
Sanchez, P., Hernandez, A.M., Stecca, B., Kahler, A.J., DeGueme, A.M., Barrett, A., Beyna,
M., Datta, M.W., Datta, S., and Altaba, A. 2004. Inhibition of prostate cancer prolifera-
tion by interference with SONIC HEDGEHOG-GLI1 signaling. Proc. Natl Acad. Sci.
USA 101:12561-12566.
Santagata, S., Demichelis, F., Riva, A., Varambally, S., Hofer, M.D., Kutok, J.L., Kim, R., Tang,
J., Montie, J.E., Chinnaiyan, A.M., Rubin, M.A., and Aster, J.C. 2004. JAGGED1 expression
is associated with prostate cancer metastasis and recurrence. Cancer Res. 64:6854-6857.
Sar, M., Lubahn, D.B., French, F.S., andWilson, E.M. 1990. Immunohistochemical localiza-
tion of the androgen receptor in rat and human tissues. Endocrinology 127:3180-3186.
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., and Brivanlou, A.H. 2004. Maintenance
of pluripotency in human and mouse embryonic stem cells through activation of Wnt
signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10:55-63.
Scher, H.I. and Sawyers, C.L. 2005. Biology of progressive, castration-resistant prostate
cancer: directed therapies targeting the androgen-receptor signaling axis. J. Clin. Oncol.
23:8253-8261.
Sell, S. 2006. Cancer stem cells and differentiation therapy. Tumour Biol. 27:59-70.
Sharifi, N., Gulley, J.L., and Dahut, W.L. 2005. Androgen deprivation therapy for prostate
cancer. JAMA 294:238-244.
Sharifi, N., Kawasaki, B.T., Hurt, E.M., and Farrar, W.L. 2006. Stem cells in prostate cancer:
resolving the castrate-resistant conundrum and implications for hormonal therapy. Can-
cer Biol. Ther. 5:901-906.
Shen, Q., Goderie, S.K., Jin, L., Karanth, N., Sun, Y., Abramova, N., Vincent, P., Pumiglia,
K., and Temple, S. 2004. Endothelial cells stimulate self-renewal and expand neurogenesis
of neural stem cells. Science 304:1338-1340.
Shou, J., Ross, S., Koeppen, H., De Sauvage, F.J., and Gao, W.Q. 2001. Dynamics of notch
expression during murine prostate development and tumorigenesis. Cancer Res.
61:7291-7297.
Shukla, S., Wu, C.P., and Ambudkar, S.V. 2008. Development of inhibitors of ATP-binding
cassette drug transporters: present status and challenges. Expert Opin. Drug Metab.
Toxicol. 4:205-223.
Siemers, E.R., Dean, R.A., Friedrich, S., Ferguson-Sells, L., Gonzales, C., Farlow, M.R., and
May, P.C. 2007. Safety, tolerability, and effects on plasma and cerebrospinal fluid amy-
loid-beta after inhibition of gamma-secretase. Clin. Neuropharmacol. 30:317-325.
Signoretti, S., Waltregny, D., Dilks, J., Isaac, B., Lin, D., Garraway, L., Yang, A., Montironi,
R., McKeon, F., and Loda, M. 2000. p63 is a prostate basal cell marker and is required for
prostate development. Am. J. Pathol. 157:1769-1775.
Signoretti, S., Pires, M.M., Lindauer, M., Horner, J.W., Grisanzio, C., Dhar, S., Majumder,
P., McKeon, F., Kantoff, P.W., Sellers, W.R., and Loda, M. 2005. p63 regulates commit-
ment to the prostate cell lineage. Proc. Natl Acad. Sci. USA 102:11355-11360.
Sims-Mourtada, J., Izzo, J.G., Ajani, J., and Chao, K.S. 2007. Sonic Hedgehog promotes
multiple drug resistance by regulation of drug transport. Oncogene 26:5674-5679.
Southam, C.M. and Brunschwig, A. 1961. Quantitative studies of autotransplantation of
human cancer. Cancer 14:971-978.
